Limbach Holdings Reports Fourth Quarter and Fiscal Year 2022 Results
Go back to Limbach Holdings Reports Fourth Quarter and Fiscal Year 2022 Results| Holmes Biopharma, Inc. (NASDAQ: LMB) | Delayed: 76.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $76.00 | 52 Week High | $0.15 | |||
| Open | $76.00 | 52 Week Low | $0.15 | |||
| Day High | $76.00 | P/E | N/A | |||
| Day Low | $76.00 | EPS | $0.00 | |||
| Volume | 82 | |||||
